» Articles » PMID: 14033060

A Plaque Assay for Respiratory Syncytial Virus

Overview
Date 1963 Mar 1
PMID 14033060
Citations 36
Authors
Affiliations
Soon will be listed here.
Citing Articles

Interferon Epsilon-Mediated Antiviral Activity Against Human Metapneumovirus and Respiratory Syncytial Virus.

Martinez-Espinoza I, Babawale P, Miletello H, Cheemarla N, Guerrero-Plata A Vaccines (Basel). 2024; 12(10).

PMID: 39460364 PMC: 11511582. DOI: 10.3390/vaccines12101198.


SARS-CoV-2 Neutralization Assays Used in Clinical Trials: A Narrative Review.

Sun Y, Huang W, Xiang H, Nie J Vaccines (Basel). 2024; 12(5).

PMID: 38793805 PMC: 11125816. DOI: 10.3390/vaccines12050554.


First Isolation and Characteristics of Bovine Parainfluenza Virus Type 3 from Yaks.

Ren Y, Chen X, Tang C, Yue H Pathogens. 2022; 11(9).

PMID: 36145395 PMC: 9503188. DOI: 10.3390/pathogens11090962.


Antiviral activity of extracellular vesicles derived from respiratory syncytial virus-infected airway epithelial cells.

Corsello T, Qu Y, Ivanciuc T, Garofalo R, Casola A Front Immunol. 2022; 13:886701.

PMID: 36032066 PMC: 9412241. DOI: 10.3389/fimmu.2022.886701.


Lack of Type I Interferon Signaling Ameliorates Respiratory Syncytial Virus-Induced Lung Inflammation and Restores Antioxidant Defenses.

Ansar M, Qu Y, Ivanciuc T, Garofalo R, Casola A Antioxidants (Basel). 2022; 11(1).

PMID: 35052571 PMC: 8772717. DOI: 10.3390/antiox11010067.